NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Pulnovo Medical

Pulnovo Medical

Private
WuxiHealthcare & Life Scienceshttp://www.pulnovomed.com/

Last Round

Strategic

Apr 19, 2026

Total Funding Raised

$200M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Pulnovo Medical is a therapeutic devices company that develops interventional therapies for treating pulmonary hypertension and heart failure.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

pulmonary artery denervationPADNradiofrequency ablationpulmonary hypertensioninterventional cardiologyRF ablationcardiovascular devicemedtechheart failureminimally invasive therapyRF ablation catheterbreakthrough deviceneuromodulationinvestigational device exemptionIDE

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pulnovo Medical Comps

Public and private peers based on sector, stage, and business model.

Pulnovo Medical comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Pulnovo Medical Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
StrategicApr 19, 2026
Series CMar 2, 2025
VC RoundNov 7, 2022
Series AAug 3, 2021

Pulnovo Medical Investors

Notable investors and investment history

Pulnovo Medical investors
InvestorRounds
YuanBio Venture CapitalVC Round
Lapam CapitalSeries C, Strategic
OrbiMedStrategic, VC Round, Series C, Series A
EQT ABStrategic
Cenova CapitalVC Round, Series A
HongShanStrategic
Lilly Asia VenturesStrategic, VC Round, Series A, Series C

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 1, 2026

    Grew 19% QoQ, from 21 to 25 employees.

  • Apr 19, 2026

    $100M raised in a strategic round.

Pulnovo Medical Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Pulnovo Medical Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Pulnovo Medical's valuation, stock price, and market status.

Firmographic Details

HeadquartersWuxi
Employee Range25
Year Founded2013
Last FundingApr 19, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.